Milestone Pharmaceuticals Inc (MIST) — Financial Flexibility Index
Milestone Pharmaceuticals Inc (MIST) has a Financial Flexibility Index of -0.15x as of September 2025. Free cash flow of $-9.81 Million (operating CF $-9.82 Million minus capex $1.98K) represents 0% of total liabilities ($67.25 Million). Also explore Milestone Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Milestone Pharmaceuticals Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Milestone Pharmaceuticals Inc across 8 annual periods. Check MIST capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Milestone Pharmaceuticals Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Milestone Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Milestone Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.46x | $-28.82 Million | $-28.85 Million | $62.35 Million | ▲ +41.7% |
| 2023 | -0.79x | $-46.31 Million | $-46.42 Million | $58.45 Million | ▲ +87.7% |
| 2022 | -6.42x | $-52.20 Million | $-52.47 Million | $8.13 Million | ▼ -40.0% |
| 2021 | -4.58x | $-33.22 Million | $-33.22 Million | $7.25 Million | ▲ +38.0% |
| 2020 | -7.39x | $-50.63 Million | $-50.73 Million | $6.86 Million | ▼ -23.9% |
| 2019 | -5.96x | $-50.74 Million | $-51.15 Million | $8.51 Million | ▼ -3959.9% |
| 2018 | -0.15x | $-21.04 Million | $-21.05 Million | $143.29 Million | ▼ -11.2% |
| 2017 | -0.13x | $-8.02 Million | $-8.05 Million | $60.71 Million | — |